Company intelligence
Microbot Medical
Step into the next generation of #endovascular intervention.
About Microbot Medical
Microbot Medical Inc. (NASDAQ: MBOT) is a commercial stage medical device company focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY® Endovascular Robotic System is the world’s first FDA cleared single-use, remotely operated robotic solution designed for precision, efficiency and safety. Backed by a strong intellectual property portfolio and a commitment to innovation, Microbot is driving the future of endovascular care.
Verified activity
Signals from Microbot Medical
2 published signals
Presence & Recognition
Microbot Medical featured Dr. Khoury on behalf of Dr. Bercu and the Emory IR team on their first experience with LIBERTY across a range of procedures.
Reported by Juan Diaz-Cartelle, M.D.
Presence & Recognition
Microbot Medical team is attending the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress in Copenhagen, Denmark from September 5 to 9, 2026.
Reported by Microbot Medical